Drug intelligence / Profile preview

heptaminol

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Heptaminol is a small molecule cardiac stimulant and vasodilator, classified as an amino alcohol. It is primarily used in the treatment of orthostatic hypotension, hemorrhoids, and venolymphatic insufficiency. Heptaminol acts as a positive inotrope (increases cardiac contractility), increases coronary blood flow, and has mild peripheral vasoconstrictor properties. Its mechanism of action is not fully understood but appears to involve interference with catecholamine (norepinephrine) release and uptake—possibly by inhibiting norepinephrine reuptake at sympathetic nerve endings—and may also stimulate Na+/H+ exchange in myocardial cells[1][5][6][8]. Heptaminol has been investigated up to phase II clinical trials for cardiovascular indications[1]. It is also listed as a prohibited substance by the World Anti-Doping Agency due to its stimulant effects[5].

Brand names
Corasore
Other names
heptaminol hydrochloride6-amino-2-methyl-2-heptanol2-heptanol, 6-amino-2-methyl-eptaminoloacéfylline heptaminoladénosine phosphate d'heptaminol
02

Targets

NET (Norepinephrine Transporter)NHE (Sodium/hydrogen exchanger 6)

Beyond the preview

Go deeper on heptaminol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heptaminol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call